NL-OMON35905CompletedNot Applicable
Effect of AN-PEP enzyme on gastrointestinal breakdown of immunogenic gluten epitopes in healthy subjects - AN-PEP-02
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- DSM Food Specialties
- Enrollment
- 17
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Age >=18 but <45 yr
- •women; hormonal contraceptive therapy
Exclusion Criteria
- •Any medical condition that may interfere with the study and may jeopardise the health status of the participant
- •women; no use of hormonal contraceptive therapy
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of AN-PEP enzyme on gluten digestion.Healthy subjects. Intended target populationgluten intolerant/sensitive peopleNL-OMON21404Dr Maaike BruinsDSM Biotechnology CentreAlexander Fleminglaan 12613 AX Delft, The Netherlands+31 15 2792056Maaike.Bruins@DSM.com12
Completed
Not Applicable
Effect of AN-PEP Enzyme on Gluten DigestionGluten DigestionNCT01335503DSM Food Specialties12
Completed
Not Applicable
Effect of AN-PEP enzyme on the effects of gluten ingestion in patients with coeliac diseaseCeliac disease patientsNL-OMON26422DSM Food Specialties14
Completed
Not Applicable
Effect of AN-PEP Enzyme on Gluten Digestion in Gluten Sensitive IndividualsNon-coeliac Gluten SensitivityNCT02060864DSM Food Specialties18
Completed
Phase 3
Efficacy of ActiPhen™ on gastrointestinal tract function in otherwise healthy adults. A randomised double blind placebo-controlled study.gastrointestinal tract functionOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12618000875202RDC Global Pty Ltd69